A cross-validation procedure for general pedigrees and matched odds ratio fitness metric implemented for the multifactor dimensionality reduction pedigree disequilibrium test.
As genetic epidemiology looks beyond mapping single disease susceptibility loci, interest in detecting epistatic interactions between genes has grown. The dimensionality and comparisons required to search the epistatic space and the inference for a significant result pose challenges for testing epistatic disease models. The multifactor dimensionality reduction-pedigree disequilibrium test (MDR-PDT) was developed to test for multilocus models in pedigree data. In the present study we rigorously tested MDR-PDT with new cross-validation (CV) (both 5- and 10-fold) and omnibus model selection algorithms by simulating a range of heritabilities, odds ratios, minor allele frequencies, sample sizes, and numbers of interacting loci. Power was evaluated using 100, 500, and 1,000 families, with minor allele frequencies 0.2 and 0.4 and broad-sense heritabilities of 0.005, 0.01, 0.03, 0.05, and 0.1 for 2- and 3-locus purely epistatic penetrance models. We also compared the prediction error (PE) measure of effect with a predicted matched odds ratio (MOR) for final model selection and testing. We report that the CV procedure is valid with the permutation test, MDR-PDT performs similarly with 5- and 10-fold CV, and that the MOR is more powerful than PE as the fitness metric for MDR-PDT.
Edwards
Todd L
TL
Center for Genetic Epidemiology and Statistical Genetics, Miami Institute for Human Genomics, University of Miami Miller School of Medicine, Florida, USA.
Torstensen
Eric
E
Dudek
Scott
S
Martin
Eden R
ER
Ritchie
Marylyn D
MD
D000465:Algorithms; D002874:Chromosome Mapping; D004843:Epistasis, Genetic; D005787:Gene Frequency; D014644:Genetic Variation; D005838:Genotype; D006801:Humans; D015810:Linkage Disequilibrium; D008957:Models, Genetic; D015233:Models, Statistical; D016017:Odds Ratio; D010375:Pedigree
J Natl Cancer Inst. 1959 Apr;22(4):719-48
13655060
Am J Hum Genet. 2001 Jul;69(1):138-47
11404819
BMC Bioinformatics. 2008 May 16;9:238
18485205
Pac Symp Biocomput. 2006;:499-510
17094264
Genet Epidemiol. 2006 Sep;30(6):546-55
16800004
Appl Soft Comput. 2004 Feb 1;4(1):79-86
20948983
Pac Symp Biocomput. 2004;:93-103
14992495
Pharmacogenomics. 2004 Sep;5(6):709-19
15335291
Stat Appl Genet Mol Biol. 2005;4:Article15
16646832
Hum Reprod. 2008 Aug;23(8):1902-9
18487217
BMC Bioinformatics. 2004 Apr 30;5:49
15119966
Am J Hum Genet. 2004 Apr;74(4):765-9
14997420
Genet Epidemiol. 2006 Feb;30(2):111-23
16374833
Genet Epidemiol. 2003 Feb;24(2):150-7
12548676
Am J Med Genet B Neuropsychiatr Genet. 2009 Jul 5;150B(5):721-35
19105203
Genet Epidemiol. 2003 Nov;25(3):203-13
14557988
Nutrition. 2004 Jan;20(1):69-73
14698017